National Heart, Lung and Blood Institute
49
2M
41
6
0.14
2
- Areas of investment
Summary
The fund has no specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Biotechnology, Software. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Centerline Biomedical, Numerate
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the National Heart, Lung and Blood Institute, startups are often financed by National Institutes of Health, U.S. Department of Defense, MedTech Innovator. In the next rounds fund is usually obtained by National Institutes of Health, National Cancer Institute.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The high activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually.
Investments analytics
Analytics
- Total investments
- 49
- Lead investments
- 6
- Exits
- 2
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (24)
- Health Care (22)
- Medical (14)
- Medical Device (10)
- Artificial Intelligence (9) Show 34 more
- Investments by region
-
- United States (45)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 26
- Group Appearance index
- 0.04
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Exeon Analytics | 17 Aug 2017 | Software, Analytics, Information Technology, Cyber Security, Network Security | Seed | 109K | Switzerland, Zurich, Zurich |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.